• 1. Design, synthesis and in silico studies of new quinazolinone derivatives as antitumor PARP-1 inhibitors
  Sayed K. Ramadan,Eman Z. Elrazaz,Khaled A. M. Abouzid,Abeer M. El-Naggar RSC Adv. 2020 10 29475
• 2. New quinoxaline-2(1H)-ones as potential VEGFR-2 inhibitors: design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations
  Reda G. Yousef,Helmy M. Sakr,Ibrahim H. Eissa,Ahmed. B. M. Mehany,Ahmed M. Metwaly,Mostafa A. Elhendawy,Mohamed M. Radwan,Mahmoud A. ElSohly,Hamada S. Abulkhair,Khaled. El-Adl New J. Chem. 2021 45 16949
• 3. Identification of new theobromine-based derivatives as potent VEGFR-2 inhibitors: design, semi-synthesis, biological evaluation, and in silico studies
  Ibrahim H. Eissa,Reda G. Yousef,Hazem Elkady,Eslam B. Elkaeed,Aisha A. Alsfouk,Dalal Z. Husein,Ibrahim M. Ibrahim,Mostafa A. Elhendawy,Murrell Godfrey,Ahmed M. Metwaly RSC Adv. 2023 13 23285

Recent Advances in the Study of N-(4-Acetylphenyl)-2-chloroacetamide (CAS: 38283-38-4) in Chemical Biology and Pharmaceutical Research

N-(4-Acetylphenyl)-2-chloroacetamide (CAS: 38283-38-4) is a chemical compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its acetylphenyl and chloroacetamide functional groups, has been explored for its reactivity and biological activity. Recent studies have focused on its role as a synthetic intermediate, its potential as a pharmacophore, and its mechanism of action in various biological systems.

One of the key areas of research involves the use of N-(4-Acetylphenyl)-2-chloroacetamide as a building block in the synthesis of more complex molecules. Its chloroacetamide moiety is particularly reactive, making it a valuable precursor in the development of novel compounds with potential therapeutic applications. Recent publications have highlighted its utility in the synthesis of heterocyclic compounds, which are often central to drug discovery efforts.

In addition to its synthetic applications, N-(4-Acetylphenyl)-2-chloroacetamide has been investigated for its biological activity. Preliminary studies suggest that it may exhibit inhibitory effects on certain enzymes, including those involved in inflammatory pathways. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound showed promising activity against cyclooxygenase-2 (COX-2), an enzyme implicated in inflammation and pain. These findings open new avenues for the development of anti-inflammatory agents.

Another significant area of research is the exploration of the compound's mechanism of action at the molecular level. Advanced techniques such as X-ray crystallography and molecular docking have been employed to elucidate its interactions with biological targets. These studies have provided insights into the structural features that contribute to its activity, which could inform the design of more potent and selective analogs.

Despite these promising developments, challenges remain in the optimization of N-(4-Acetylphenyl)-2-chloroacetamide for therapeutic use. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed through further research. Recent efforts have focused on modifying the compound's structure to improve its pharmacokinetic properties while retaining its biological activity.

In conclusion, N-(4-Acetylphenyl)-2-chloroacetamide (CAS: 38283-38-4) represents a versatile and promising compound in chemical biology and pharmaceutical research. Its dual role as a synthetic intermediate and a biologically active molecule underscores its potential in drug discovery. Ongoing studies are expected to further elucidate its applications and pave the way for the development of novel therapeutics.

• 140-49-8(N-4-(2-chloroacetyl)phenylacetamide)
• 150667-24-6(4-Acetamidoacetophenone)
• 90767-96-7(Acetamide,N-(4-acetylphenyl)-2,2,2-trichloro-)
• 42865-69-0(N-(3-acetylphenyl)-2-chloroacetamide)
• 20172-36-5(N-(Chloroacetyl)4-ethylaniline)
• 380346-54-3(2-Chloro-N-(3-ethylphenyl)acetamide)
• 143210-98-4(2-Chloro-N-(9,10-dioxo-9,10-dihydroanthracen-2-yl)acetamide)
• 2719-21-3(4'-Acetamidoacetophenone)
• 23207-75-2(N-(2-Benzoylphenyl)-2-chloroacetamide)
• 1527-61-3(2-Chloro-N-(4-isopropylphenyl)acetamide)